These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 4729722

  • 21. Spironolactone and chlorthalidone in uncontrolled elderly hypertensive patients treated with calcium antagonists and angiotensin II receptor-blocker: effects on endothelial function, inflammation, and oxidative stress.
    Yamanari H, Nakamura K, Miura D, Yamanari S, Ohe T.
    Clin Exp Hypertens; 2009 Oct; 31(7):585-94. PubMed ID: 19886856
    [Abstract] [Full Text] [Related]

  • 22. Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosternosm.
    Helmer OM, Judson WE.
    Circulation; 1968 Nov; 38(5):965-76. PubMed ID: 5697693
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Is essential hypertension still a disease entity? Definition of hyporeninemic hypertension].
    Distler A.
    Internist (Berl); 1974 Mar; 15(3):146-54. PubMed ID: 4600300
    [No Abstract] [Full Text] [Related]

  • 27. [Plasma renin activity in essential hypertension: different short- und long-term effects of diuretics (author's transl)].
    Esch I, Placheta P, Gaul G.
    Wien Klin Wochenschr; 1976 Jun 25; 88(13):415-8. PubMed ID: 824860
    [Abstract] [Full Text] [Related]

  • 28. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A, Mahgoub M, Hall M, Feely J.
    Am J Hypertens; 2005 Dec 25; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [Abstract] [Full Text] [Related]

  • 29. Renin reactivity as a determinant of responsiveness to antihypertensive treatment.
    Weber MA, Lopez-Ovejero JA, Drayer JI, Case DB, Laragh JH.
    Arch Intern Med; 1977 Mar 25; 137(3):284-9. PubMed ID: 843146
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ, Davies DL, Ferriss JB, Fraser R, Haywood E, Lever AF, Robertson JI.
    Br Med J; 1972 Jun 24; 2(5816):729-34. PubMed ID: 4338668
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the efficacy and safety of a hydrochlorothiazide to chlorthalidone medication change in veterans with hypertension.
    Matthews KA, Brenner MJ, Brenner AC.
    Clin Ther; 2013 Sep 24; 35(9):1423-30. PubMed ID: 23993697
    [Abstract] [Full Text] [Related]

  • 34. Suppressed plasma renin activity in essential hypertension. Roles of plasma volume, blood pressure, and sympathetic nervous system.
    Jose A, Crout JR, Kaplan NM.
    Ann Intern Med; 1970 Jan 24; 72(1):9-16. PubMed ID: 4312105
    [No Abstract] [Full Text] [Related]

  • 35. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ, Taylor KP, Ashby MJ, Brown MJ.
    Circulation; 2007 Jul 17; 116(3):268-75. PubMed ID: 17606839
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)].
    Distler A, Keim HJ, Philipp T, Philippi A, Walter U, Werner E.
    Dtsch Med Wochenschr; 1974 Apr 26; 99(17):864-9. PubMed ID: 4834874
    [No Abstract] [Full Text] [Related]

  • 38. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S, Bernheim J, Podjarny E.
    Isr Med Assoc J; 2002 Jan 26; 4(1):17-20. PubMed ID: 11802302
    [Abstract] [Full Text] [Related]

  • 39. Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.
    Karlberg BE, Kågedal B, Tegler L, Tolagen K, Bergman B.
    Am J Cardiol; 1976 Mar 31; 37(4):642-9. PubMed ID: 769527
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.